Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial.
Cooke SA, de Ruysscher D, Reymen B, Lambrecht M, Fredberg Persson G, Faivre-Finn C, Dieleman EMT, Lewensohn R, van Diessen JNA, Sikorska K, Lalezari F, Vogel W, van Elmpt W, Damen EMF, Sonke JJ, Belderbos JSA. Cooke SA, et al. Among authors: van elmpt w, van diessen jna. Radiother Oncol. 2023 Apr;181:109492. doi: 10.1016/j.radonc.2023.109492. Epub 2023 Jan 24. Radiother Oncol. 2023. PMID: 36706958 Clinical Trial.
The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer.
Lambin P, Petit SF, Aerts HJ, van Elmpt WJ, Oberije CJ, Starmans MH, van Stiphout RG, van Dongen GA, Muylle K, Flamen P, Dekker AL, De Ruysscher D. Lambin P, et al. Among authors: van stiphout rg, van dongen ga, van elmpt wj. Radiother Oncol. 2010 Aug;96(2):145-52. doi: 10.1016/j.radonc.2010.07.001. Epub 2010 Jul 19. Radiother Oncol. 2010. PMID: 20647155
Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.
van Loon J, Offermann C, Ollers M, van Elmpt W, Vegt E, Rahmy A, Dingemans AM, Lambin P, De Ruysscher D. van Loon J, et al. Among authors: van elmpt w. Radiother Oncol. 2011 May;99(2):172-5. doi: 10.1016/j.radonc.2011.03.014. Epub 2011 May 14. Radiother Oncol. 2011. PMID: 21571382 Free PMC article.
The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer.
van Elmpt W, De Ruysscher D, van der Salm A, Lakeman A, van der Stoep J, Emans D, Damen E, Öllers M, Sonke JJ, Belderbos J. van Elmpt W, et al. Among authors: van der stoep j, van der salm a. Radiother Oncol. 2012 Jul;104(1):67-71. doi: 10.1016/j.radonc.2012.03.005. Epub 2012 Apr 6. Radiother Oncol. 2012. PMID: 22483675 Clinical Trial.
State of the art radiation therapy for lung cancer 2012: a glimpse of the future.
De Ruysscher D, Belderbos J, Reymen B, van Elmpt W, van Baardwijk A, Wanders R, Hoebers F, Vooijs M, Ollers M, Lambin P. De Ruysscher D, et al. Among authors: van baardwijk a, van elmpt w. Clin Lung Cancer. 2013 Mar;14(2):89-95. doi: 10.1016/j.cllc.2012.06.006. Epub 2012 Jul 31. Clin Lung Cancer. 2013. PMID: 22853981 Review.
175 results